Evidence map›Paper›PMID 20160609›Full record

ReviewShock (Augusta, Ga.)2010

Fluid resuscitation: past, present, and the future.

Heena P Santry, Hasan B Alam

Open access · greenAbstract readReview
In one paragraph

Review in Shock (Augusta, Ga.), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 1 pooled it
14.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 1 synthesis or guideline pooled it, 255 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Acute management of spinal fractures: What you need to know.The journal of trauma and acute care surgery · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Fluid resuscitation in trauma: what are the best strategies and fluids?International journal of emergency medicine · 2019
    Review
  13. Resuscitation with centhaquin and 6% hydroxyethyl starch 130/0.4 improves survival in a swine model of hemorrhagic shock: a randomized experimental study.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2019
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Heena P SantryDepartment of Surgery, Division of Trauma, Emergency Surgery, and Surgical Critical Care, Massachusetts General Hospital/Harvard Medical School, Boston, MA 02114, USA.
Hasan B Alam
Massachusetts General Hospital · US

Funding

Modulation of Acetylation in the Treatment of Lethal InjuriesR01GM084127 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ALAM, HASAN B · 2009 to 2019
$2.6M
NIGMS NIH HHS R01 GM084127
6 · The paper itself

Abstract

Hemorrhage remains a major cause of preventable death following both civilian and military trauma. The goals of resuscitation in the face of hemorrhagic shock are restoring end-organ perfusion and maintaining tissue oxygenation while attempting definitive control of bleeding. However, if not performed properly, resuscitation can actually exacerbate cellular injury caused by hemorrhagic shock, and the type of fluid used for resuscitation plays an important role in this injury pattern. This article reviews the historical development and scientific underpinnings of modern resuscitation techniques. We summarized data from a number of studies to illustrate the differential effects of commonly used resuscitation fluids, including isotonic crystalloids, natural and artificial colloids, hypertonic and hyperoncotic solutions, and artificial oxygen carriers, on cellular injury and how these relate to clinical practice. The data reveal that a uniformly safe, effective, and practical resuscitation fluid when blood products are unavailable and direct hemorrhage control is delayed has been elusive. Yet, it is logical to prevent this cellular injury through wiser resuscitation strategies than attempting immunomodulation after the damage has already occurred. Thus, we describe how some novel resuscitation strategies aimed at preventing or ameliorating cellular injury may become clinically available in the future.

Indexed as

AnimalsBlood SubstitutesClinical Trials as TopicColloidsCrystalloid SolutionsFluid TherapyHemoglobinsHemorrhageHistone Deacetylase InhibitorsHumansIsotonic SolutionsRehydration SolutionsResuscitationRinger's LactateShock, HemorrhagicBlood SubstitutesColloidsCrystalloid SolutionsHBOC 201HemoglobinsHistone Deacetylase InhibitorsIsotonic SolutionsRehydration SolutionsRinger's Lactate

Identifiers

PMID20160609
PMCPMC4988844
OpenAlexW1986251166

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.